Insider trades
Andrew Cittadine, COO of Monopar Therapeutics MNPR, has filed 10 purchases and 0 sales on the open market. The latest trade was on 09/30.
Andrew Cittadine
COO
- Company
- Monopar Therapeutics MNPR
- First filing
- 23/01/03
- Trades
- 62 trades
- Buys / sales
- 10 / 0
- 12-month net buying
- No record
- Last trade
- 09/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MNPR | Open-market buy | 24/06/18–24/06/20 | 24/06/21 | 32,508 sh2 trades | $0.78avg. | $25,495.92 | +21.2% |
MNPR | Open-market buy | 24/06/13–24/06/17 | 24/06/17 | 36,000 sh3 trades | $0.91avg. | $32,880 | +30.6% |
MNPR | Open-market buy | 24/06/03–24/06/04 | 24/06/05 | 24,000 sh2 trades | $0.77avg. | $18,480 | +25.6% |
MNPR | Open-market buy | 24/05/29–24/05/31 | 24/05/31 | 36,000 sh3 trades | $0.64avg. | $23,040 | +62.5% |